Warabi, Japan

Masao Wada

This inventor holds 1 USPTO granted patent. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masao Wada. Retrieved from https://idiyas.com/inventor/masao-wada-2ugxhnko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masao Wada: Innovator in Prostaglandin-like Compounds

Introduction

Masao Wada is a notable inventor based in Warabi, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with therapeutic applications.

Latest Patents

Wada holds a patent for 8-Azaprostanoic acid derivatives. This patent discloses novel 8-azaprostanoic acid derivatives and processes for preparing them. The compounds are characterized by the formula: ##STR1##, where R.sup.1 is hydrogen or an alkyl group of 2 to 6 carbon atoms, R.sup.2 is hydrogen or methyl, and R.sup.3 is hydrogen. These derivatives exhibit Prostaglandin-like activities and are useful as bronchodilators, stimulating agents for childbirth, abortion or labor, and for the treatment of gastrointestinal disorders. He has 1 patent to his name.

Career Highlights

Masao Wada is associated with Tanabe Seiyaku Company, Limited, where he has been instrumental in research and development. His work has contributed to advancements in pharmaceutical formulations and therapeutic agents.

Collaborations

Wada has collaborated with notable colleagues such as Shoichi Harigaya and Junichi Himizu. Their combined efforts have led to innovative solutions in the field of medicinal chemistry.

Conclusion

Masao Wada's contributions to the development of 8-azaprostanoic acid derivatives highlight his role as a key innovator in the pharmaceutical industry. His work continues to impact therapeutic practices and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…